What Can We Learn about SARS-CoV-2 Prevalence from Testing and Hospital Data?
Daniel W. Sacks,
Nir Menachemi,
Peter Embí and
Coady Wing
Additional contact information
Daniel W. Sacks: Indiana University
Nir Menachemi: Indiana University and Regenstrief Institute, Inc.
Peter Embí: Vanderbilt University Medical Center and Vanderbilt University
Coady Wing: Indiana University
The Review of Economics and Statistics, 2024, vol. 106, issue 3, 848-858
Abstract:
Measuring the prevalence of active SARS-CoV-2 infections in the general population is difficult because tests are conducted on a small and nonrandom segment of the population. However, hospitalized patients are tested at very high rates, even those admitted for non-COVID reasons. We show how to use information on testing of non-COVID hospitalized patients to obtain tight bounds on population prevalence, under conditions weaker than those usually used. We apply our approach to the population of test and hospitalization data for Indiana, and we validate our approach. Our bounds could be constructed at relatively low cost, and for other heavily tested populations.
Date: 2024
References: Add references at CitEc
Citations:
Downloads: (external link)
https://doi.org/10.1162/rest_a_01179
Access to PDF is restricted to subscribers.
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:tpr:restat:v:106:y:2024:i:3:p:848-858
Ordering information: This journal article can be ordered from
https://mitpressjour ... rnal/?issn=0034-6535
Access Statistics for this article
The Review of Economics and Statistics is currently edited by Pierre Azoulay, Olivier Coibion, Will Dobbie, Raymond Fisman, Benjamin R. Handel, Brian A. Jacob, Kareen Rozen, Xiaoxia Shi, Tavneet Suri and Yi Xu
More articles in The Review of Economics and Statistics from MIT Press
Bibliographic data for series maintained by The MIT Press ().